Nuo Therapeutics, Inc.
AURX · OTCMCIK 1091596fmd_0DYFZ7XTEVZ7DGJT6WJ0KXKZP4Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2010 to Jun 30, 2026, 65 periods
| Line item | FY2015 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 12 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 3 |
| Cost of revenue | 8 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Gross profit | 4 | (0) | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 2 |
| Research and development | 3 | 1 | 1 | 0 | 0 | 0 | – | – | – | – |
| Selling, general and administrative | 15 | 5 | 2 | 1 | 0 | 0 | 3 | 4 | 4 | 5 |
| Total operating expenses | 45 | 15 | 3 | 1 | 0 | 0 | 3 | 4 | 4 | 5 |
| Compensation and benefits | – | – | – | – | – | – | – | 2 | 2 | 3 |
| Operating income | (41) | (16) | (2) | (1) | (0) | (0) | (3) | (3) | (2) | (3) |
| Interest expense | 39 | 0 | 0 | 0 | 0 | 0 | – | – | – | – |
| Interest and investment income | 0 | – | – | – | – | – | – | – | – | – |
| Other non-operating income (expense) | (12) | 1 | (0) | (0) | 0 | 0 | 0 | 0 | 0 | 0 |
| Income before taxes | (53) | (15) | (2) | (1) | (0) | (0) | (3) | (3) | (2) | (3) |
| Income tax expense | (0) | – | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (53) | – | – | (1) | (0) | (0) | (3) | (3) | (2) | (3) |
| Net income | (53) | (15) | (2) | (1) | (0) | (0) | (3) | (3) | (2) | (3) |
| Net income to common shareholders | – | (15) | (2) | (1) | 8 | (1) | (3) | – | – | – |